Signal
Cross-Border Impact Ventures Hits $58M First Close for Global Healthtech Fund
- Category
- · Funding · Global
- Date
- August 6, 2026
- Source
- OVUM
Summary
The Toronto-based firm secured initial capital for its second fund targeting women's and children's health technologies. With a $125 million final goal, the fund focuses on Series A companies scaling innovations across both emerging and developed markets.
The company works in women's health, and this round at Series A ($58M) is new money into that part of the market. Compare it with other recent rounds to see whether prices here are rising or holding steady.
OVUM interpretation layer
The editorial read on this signal — pattern, market-structure implications, and what to watch next.
Sources
- OVUM Primary source
The OVUM Intelligence Brief
Keep reading past this page
The week's funding, launches, and studies in women's health, in plain English.
Weekly. No spam. Unsubscribe anytime.